Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11.6Revenue (TTM) $M0.6Net Margin (%)-337.6Altman Z-Score-6.1
Enterprise Value $M13.7EPS (TTM) $-0.1Operating Margin %-370.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score5.6Pre-tax Margin (%)-331.4Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsN
Price/Sales18.35-y EBITDA Growth Rate %-44.5Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-13.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-19.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M27.9ROIC % (ttm)-18.2Gross Margin Increase y-yY

Gurus Latest Trades with IGC

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IGC is held by these investors:



IGC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Oliveira Steven Michael10% Owner 2009-05-20Sell42,399$9.7-95.67view
Oliveira Steven Michael10% Owner 2009-05-19Sell111,303$11.8-96.44view

Press Releases about IGC :

Quarterly/Annual Reports about IGC:

News about IGC:

Articles On GuruFocus.com
IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispen Oct 18 2017 
NYSE American Extends India Globalization Capital Compliance Plan Period Oct 12 2017 
IGC Prepares a Liquid Delivery Formulation of IGC-AD1 for Alzheimer’s Based on Novel In Vitro D Oct 04 2017 
IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Da Sep 18 2017 
IGC’s Drug Candidate for Alzheimer’s Potentially Presents New Molecular Pathway for THC to Sep 11 2017 
IGC Announces Financial Results for Quarter Ended June 30, 2017 Aug 21 2017 
IGC Builds Team Adding Industry Leader Dr. Chuanhai Cao, an expert on THC-Based Alzheimer’s Dis Aug 01 2017 
IGC Announces Financial Results for Fiscal Year Ended March 31, 2017 Jul 14 2017 
IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease Jun 12 2017 
IGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, C May 16 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK